Galmed Pharmaceuticals Ltd. (GLMD) Social Stream
GALMED PHARMACEUTICALS LTD (GLMD) Price Targets From Analysts
Use the tables below to see what analysts covering GALMED PHARMACEUTICALS LTD think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 5 | $25 | $6 | $17 | $0.449 | 3686.19% |
| 2021-12-01 | 3 | $25 | $6 | $17 | $0.449 | 3686.19% |
| 2022-04-08 | 4 | $25 | $3 | $16.4 | $0.449 | 3552.56% |
| 2022-05-02 | 4 | $21 | $3 | $12 | $0.449 | 2572.61% |
| 2022-05-04 | 4 | $5 | $3 | $4.5 | $0.449 | 902.23% |
| 2022-05-18 | 4 | $5 | $3 | $4.333 | $0.449 | 865.03% |
| 2022-06-03 | 4 | $5 | $1.5 | $3.833 | $0.449 | 753.67% |
| 2022-08-05 | 4 | $5 | $0.7 | $2.4 | $0.449 | 434.52% |
| 2022-08-08 | 2 | $14.992 | $14.992 | $14.992 | $0.449 | 3238.98% |
| 2023-07-24 | 2 | $4 | $4 | $4 | $0.449 | 790.87% |
| 2023-09-08 | 1 | $4 | $4 | $4 | $0.449 | 790.87% |
| 2023-12-08 | 1 | $1 | $1 | $1 | $0.449 | 122.72% |
The Trend in the Analyst Price Target
GLMD's average price target has moved down $19.5 over the prior 43 months.
Over the past 137 days, GLMD's average upside potential has been 378.18%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-07-24 | 1 | 4.000 | 4 | 4.000 | 1.210 | 230.58% |
| 2023-07-24 | 1 | 14.992 | 4 | 9.496 | 1.210 | 684.79% |
| 2023-07-24 | 2 | 14.992 | 4 | 9.496 | 1.210 | 684.79% |
| 2023-09-08 | 1 | 4.000 | 4 | 4.000 | 0.806 | 396.28% |
| 2023-11-22 | 1 | 1.000 | 1 | 1.000 | 0.294 | 240.14% |
GLMD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 19 months, GLMD's average broker recommendation rating improved by 1.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- GALMED PHARMACEUTICALS LTD's upside potential (average analyst target price relative to current price) is higher than 1962.34% of all US stocks.
- GLMD has a greater average analyst price target than 179.01% of all US stocks.
- GALMED PHARMACEUTICALS LTD's number of analysts covering the stock is greater than 210.05% of all US stocks.
- GALMED PHARMACEUTICALS LTD's variance in analysts' estimates is lower than -1051.85% of all US stocks.
Stocks similar to GALMED PHARMACEUTICALS LTD in the Pharmaceutical Products industry regarding analyst recommendations and price targets are EDSA, DARE, and AGRX.
View All Top Stocks by Price Target
Make investment decisions regarding GLMD using the data that counts. Try POWR Ratings for free.